| Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies A Antoniou, PDP Pharoah, S Narod, HA Risch, JE Eyfjord, JL Hopper, ... American journal of human genetics 72 (5), 1117, 2003 | 3911 | 2003 |
| Genome-wide association study identifies novel breast cancer susceptibility loci DF Easton, KA Pooley, AM Dunning, PDP Pharoah, D Thompson, ... Nature 447 (7148), 1087-1093, 2007 | 2548 | 2007 |
| Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations TR Rebbeck, HT Lynch, SL Neuhausen, SA Narod, L Van't Veer, ... New England Journal of Medicine 346 (21), 1616-1622, 2002 | 1681 | 2002 |
| Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality SM Domchek, TM Friebel, CF Singer, DG Evans, HT Lynch, C Isaacs, ... Jama 304 (9), 967-975, 2010 | 1263 | 2010 |
| Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group TR Rebbeck, T Friebel, HT Lynch, SL Neuhausen, L van’t Veer, JE Garber, ... Journal of Clinical Oncology 22 (6), 1055-1062, 2004 | 1240 | 2004 |
| Low-penetrance susceptibility to breast cancer due to CHEK2* 1100delC in noncarriers of BRCA1 or BRCA2 mutations H Meijers-Heijboer, A van den Ouweland, J Klijn, M Wasielewski, ... Nature genetics 31 (1), 55-59, 2002 | 1211* | 2002 |
| Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). MO Leach, CR Boggis, AK Dixon, DF Easton, RA Eeles, DG Evans, ... Lancet 365 (9473), 1769, 2005 | 1172 | 2005 |
| Malignant peripheral nerve sheath tumours in neurofibromatosis 1 DGR Evans, ME Baser, J McGaughran, S Sharif, E Howard, A Moran Journal of medical genetics 39 (5), 311-314, 2002 | 1069 | 2002 |
| Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002) SR Cairns, JH Scholefield, RJ Steele, MG Dunlop, HJW Thomas, ... Gut 59 (5), 666-689, 2010 | 1032 | 2010 |
| Large-scale genotyping identifies 41 new loci associated with breast cancer risk K Michailidou, P Hall, A Gonzalez-Neira, M Ghoussaini, J Dennis, ... Nature genetics 45 (4), 353-361, 2013 | 1024 | 2013 |
| Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers KB Kuchenbaecker, JL Hopper, DR Barnes, KA Phillips, TM Mooij, ... Jama 317 (23), 2402-2416, 2017 | 985 | 2017 |
| PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene N Rahman, S Seal, D Thompson, P Kelly, A Renwick, A Elliott, S Reid, ... Nature genetics 39 (2), 165-167, 2007 | 980 | 2007 |
| The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in … SR Lakhani, MJ Van De Vijver, J Jacquemier, TJ Anderson, PP Osin, ... Journal of clinical oncology 20 (9), 2310-2318, 2002 | 946 | 2002 |
| Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial J Burn, AM Gerdes, F Macrae, JP Mecklin, G Moeslein, S Olschwang, ... The Lancet 378 (9809), 2081-2087, 2011 | 923 | 2011 |
| Guidelines for the diagnosis and management of individuals with neurofibromatosis 1 RE Ferner, SM Huson, N Thomas, C Moss, H Willshaw, DG Evans, ... Journal of medical genetics 44 (2), 81-88, 2007 | 889 | 2007 |
| A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24. 21 I Tomlinson, E Webb, L Carvajal-Carmona, P Broderick, Z Kemp, S Spain, ... Nature genetics 39 (8), 984-988, 2007 | 858 | 2007 |
| Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls N Craddock, ME Hurles, N Cardin, RD Pearson, V Plagnol, S Robson, ... Nature 464 (7289), 713, 2010 | 827 | 2010 |
| First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. J Cuzick, JF Forbes, I Sestak, S Cawthorn, H Hamed, K Holli, A Howell, ... The Lancet 360, 817-824, 2002 | 795 | 2002 |
| Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas C Palles, JB Cazier, KM Howarth, E Domingo, AM Jones, P Broderick, ... Nature Genetics, 2012 | 774 | 2012 |
| Oral contraceptives and the risk of hereditary ovarian cancer SA Narod, H Risch, R Moslehi, A Dørum, S Neuhausen, H Olsson, ... New England Journal of Medicine 339 (7), 424-428, 1998 | 772 | 1998 |
Anthony Howell, Howell A, Howell TProfessor of Medical Oncology, Manchester UniversityVerified email at picr.man.ac.uk
